MMG22 Potently Blocks Hyperalgesia in Cisplatin-treated Mice
- 16 February 2023
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 516, 54-61
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 47 references indexed in Scilit:
- Cannabinoid Type-1 Receptor Reduces Pain and Neurotoxicity Produced by ChemotherapyThe Journal of Neuroscience, 2012
- The Maintenance of Cisplatin- and Paclitaxel-Induced Mechanical and Cold Allodynia is Suppressed by Cannabinoid CB2 Receptor Activation and Independent of CXCR4 Signaling in Models of Chemotherapy-Induced Peripheral NeuropathyMolecular Pain, 2012
- Perturbing PSD-95 Interactions With NR2B-subtype Receptors Attenuates Spinal Nociceptive Plasticity and Neuropathic PainMolecular Therapy, 2011
- Role of TNF-alpha during central sensitization in preclinical studiesNeurological Sciences, 2011
- Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural PlasticityThe Journal of Pain, 2009
- Comparison of Oxaliplatin- and Cisplatin-Induced Painful Peripheral Neuropathy in the RatThe Journal of Pain, 2009
- Behavioral and electrophysiological studies in rats with cisplatin-induced chemoneuropathyBrain Research, 2008
- Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-l-carnitinePain, 2008
- NMDA receptor antagonist treatment at the time of nerve injury prevents injury-induced changes in spinal NR1 and NR2B subunit expression and increases the sensitivity of residual pain behaviours to subsequently administered NMDA receptor antagonistsPain, 2005
- Pain due to nerve damage: Are inflammatory mediators involvedInflammation Research, 1995